BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

875 related articles for article (PubMed ID: 26806101)

  • 21. Epidemiology of candidemia in Qatar, the Middle East: performance of MALDI-TOF MS for the identification of Candida species, species distribution, outcome, and susceptibility pattern.
    Taj-Aldeen SJ; Kolecka A; Boesten R; Alolaqi A; Almaslamani M; Chandra P; Meis JF; Boekhout T
    Infection; 2014 Apr; 42(2):393-404. PubMed ID: 24352810
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Breakthrough candidemia after the introduction of broad spectrum antifungal agents: A 5-year retrospective study.
    Breda GL; Tuon FF; Meis JF; Herkert PF; Hagen F; de Oliveira LZ; Dias VC; da Cunha CA; Queiroz-Telles F
    Med Mycol; 2018 Jun; 56(4):406-415. PubMed ID: 29420820
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epidemiology of bloodstream Candida species in a Spanish tertiary care hospital as a guide for implementation of T2MR (T2CANDIDA®) for rapid diagnosis of candidemia.
    Falces-Romero I; Romero-Gómez MP; Moreno-Ramos F; Mingorance J; García-Rodríguez J; Cendejas-Bueno E
    Med Mycol; 2021 Apr; 59(4):350-354. PubMed ID: 32634233
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Epidemiology and antifungal susceptibility of species producing candidemia in Valdivia, Chile].
    Márquez F; Iturrieta I; Calvo M; Urrutia M; Godoy-Martínez P
    Rev Chilena Infectol; 2017 Oct; 34(5):441-446. PubMed ID: 29488585
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Epidemiology and Susceptibility of Candidemia in Jerusalem, Israel.
    Israel S; Amit S; Israel A; Livneh A; Nir-Paz R; Korem M
    Front Cell Infect Microbiol; 2019; 9():352. PubMed ID: 31681629
    [No Abstract]   [Full Text] [Related]  

  • 26. Changing epidemiology of candidemia in a medical center in middle Taiwan.
    Hii IM; Chang HL; Lin LC; Lee YL; Liu YM; Liu CE; Chen CH; Cheng YR; Chang CY
    J Microbiol Immunol Infect; 2015 Jun; 48(3):306-15. PubMed ID: 24113067
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Surveillance study of species distribution, antifungal susceptibility and mortality of nosocomial candidemia in a tertiary care hospital in China.
    Ma CF; Li FQ; Shi LN; Hu YA; Wang Y; Huang M; Kong QQ
    BMC Infect Dis; 2013 Jul; 13():337. PubMed ID: 23875950
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Initial use of echinocandins does not negatively influence outcome in Candida parapsilosis bloodstream infection: a propensity score analysis.
    Fernández-Ruiz M; Aguado JM; Almirante B; Lora-Pablos D; Padilla B; Puig-Asensio M; Montejo M; García-Rodríguez J; Pemán J; Ruiz Pérez de Pipaón M; Cuenca-Estrella M; ; ;
    Clin Infect Dis; 2014 May; 58(10):1413-21. PubMed ID: 24642553
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Distribution and drug susceptibilities of Candida species causing candidemia from a medical center in central Taiwan.
    Chang TP; Ho MW; Yang YL; Lo PC; Lin PS; Wang AH; Lo HJ
    J Infect Chemother; 2013 Dec; 19(6):1065-71. PubMed ID: 23732308
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epidemiology of candidemia and antifungal susceptibility in invasive Candida species in the Asia-Pacific region.
    Wang H; Xu YC; Hsueh PR
    Future Microbiol; 2016 Oct; 11():1461-1477. PubMed ID: 27750452
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Candidemia in Adults at a Tertiary Hospital in China: Clinical Characteristics, Species Distribution, Resistance, and Outcomes.
    Lin S; Chen R; Zhu S; Wang H; Wang L; Zou J; Yan J; Zhang X; Farmakiotis D; Tan X; Mylonakis E
    Mycopathologia; 2018 Aug; 183(4):679-689. PubMed ID: 29572768
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nosocomial bloodstream infections due to Candida spp. in the USA: species distribution, clinical features and antifungal susceptibilities.
    Wisplinghoff H; Ebbers J; Geurtz L; Stefanik D; Major Y; Edmond MB; Wenzel RP; Seifert H
    Int J Antimicrob Agents; 2014 Jan; 43(1):78-81. PubMed ID: 24182454
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Candida glabrata: an emerging pathogen in Brazilian tertiary care hospitals.
    Colombo AL; Garnica M; Aranha Camargo LF; Da Cunha CA; Bandeira AC; Borghi D; Campos T; Senna AL; Valias Didier ME; Dias VC; Nucci M
    Med Mycol; 2013 Jan; 51(1):38-44. PubMed ID: 22762208
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increasing incidence of Candida parapsilosis candidemia with caspofungin usage.
    Forrest GN; Weekes E; Johnson JK
    J Infect; 2008 Feb; 56(2):126-9. PubMed ID: 18082269
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry.
    Horn DL; Neofytos D; Anaissie EJ; Fishman JA; Steinbach WJ; Olyaei AJ; Marr KA; Pfaller MA; Chang CH; Webster KM
    Clin Infect Dis; 2009 Jun; 48(12):1695-703. PubMed ID: 19441981
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Seven-year trend analysis of nosocomial candidemia and antifungal (fluconazole and caspofungin) use in Intensive Care Units at a Brazilian University Hospital.
    Girão E; Levin AS; Basso M; Gobara S; Gomes LB; Medeiros EA; Costa SF
    Med Mycol; 2008 Sep; 46(6):581-8. PubMed ID: 19180727
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epidemiology and predictive factors for early and late mortality in Candida bloodstream infections: a population-based surveillance in Spain.
    Puig-Asensio M; Padilla B; Garnacho-Montero J; Zaragoza O; Aguado JM; Zaragoza R; Montejo M; Muñoz P; Ruiz-Camps I; Cuenca-Estrella M; Almirante B; ; ;
    Clin Microbiol Infect; 2014 Apr; 20(4):O245-54. PubMed ID: 24125548
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Candida albicans and non-Candida albicans fungemia in an institutional hospital during a decade.
    Parmeland L; Gazon M; Guerin C; Argaud L; Lehot JJ; Bastien O; Allaouchiche B; Michallet M; Picot S; Bienvenu AL;
    Med Mycol; 2013 Jan; 51(1):33-7. PubMed ID: 22680978
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Epidemiology of candidemia: a one-year prospective observational study in the west of France].
    Talarmin JP; Boutoille D; Tattevin P; Dargère S; Weinbreck P; Ansart S; Chennebault JM; Hutin P; Léautez-Nainville S; Gay-Andrieu F; Raffi F;
    Med Mal Infect; 2009 Dec; 39(12):877-85. PubMed ID: 19346088
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epidemiology of Candidemia in Children over 7 Years in a Medical Center in Turkey.
    Yılmaz-Ciftdoğan D; Kara-Aksay A; Erbaş G; Sarkış ÜB; Karadağ-Oncel E; Anıl AB; Baran M; Er H; Yılmaz N
    Microbiol Spectr; 2021 Oct; 9(2):e0045321. PubMed ID: 34550003
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 44.